Cargando…

Unveiling drug-tolerant and persister-like cells in Leishmania braziliensis lines derived from patients with cutaneous leishmaniasis

INTRODUCTION: Resistance against anti-Leishmania drugs (DR) has been studied for years, giving important insights into long-term adaptations of these parasites to drugs, through genetic modifications. However, microorganisms can also survive lethal drug exposure by entering into temporary quiescence...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jara, Marlene, Arevalo, Jorge, Llanos-Cuentas, Alejandro, den Broeck, Frederik Van, Domagalska, Malgorzata Anna, Dujardin, Jean-Claude
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543814/ https://www.ncbi.nlm.nih.gov/pubmed/37790908 http://dx.doi.org/10.3389/fcimb.2023.1253033

Ejemplares similares

Genome diversity of Leishmania aethiopica
por: Hadermann, Amber, et al.
Publicado: (2023)

The Influence of Infection by Different Leishmania (Viannia) braziliensis Isolates on the Pathogenesis of Disseminated Leishmaniasis
por: Oliveira, Walker N., et al.
Publicado: (2021)

Quantification of Leishmania (Viannia) Kinetoplast DNA in Ulcers of Cutaneous Leishmaniasis Reveals Inter-site and Inter-sampling Variability in Parasite Load
por: Suárez, Milagros, et al.
Publicado: (2015)

Leishmania braziliensis Infection Enhances Toll-Like Receptors 2 and 4 Expression and Triggers TNF-α and IL-10 Production in Human Cutaneous Leishmaniasis
por: Polari, Ludmila P., et al.
Publicado: (2019)

The Presence of Leishmania braziliensis DNA in the Nasal Mucosa of Cutaneous Leishmaniasis Patients and the Search for Possible Clinical and Immunological Patterns of Disease Progression: A Cross Sectional Study
por: Barroso, Daniel Holanda, et al.
Publicado: (2021)

Pioglitazone, a Peroxisome Proliferator-Activated Receptor-γ Agonist, Downregulates the Inflammatory Response in Cutaneous Leishmaniasis Patients Without Interfering in Leishmania braziliensis Killing by Monocytes
por: Nascimento, Maurício T., et al.
Publicado: (2022)

Leishmania braziliensis: Strain-Specific Modulation of Phagosome Maturation
por: da Silva Vieira, Tamara, et al.
Publicado: (2019)

Therapy of cutaneous leishmaniasis caused by Leishmania braziliensis with fluconazole
por: Veraldi, Stefano, et al.
Publicado: (2021)

Healed Lesions of Human Cutaneous Leishmaniasis Caused By Leishmania major Do Not Shelter Persistent Residual Parasites
por: Sghaier, Rabiaa M., et al.
Publicado: (2022)

Transforming Growth Factor Beta (TGFβ1) and Epidermal Growth Factor (EGF) as Biomarkers of Leishmania (V) braziliensis Infection and Early Therapeutic Response in Cutaneous Leishmaniasis: Studies in Hamsters
por: Montoya, Andrés, et al.
Publicado: (2018)

Genomic Diversification, Structural Plasticity, and Hybridization in Leishmania (Viannia) braziliensis
por: Patino, Luz H., et al.
Publicado: (2020)

Therapeutic effect of oral quercetin in hamsters infected with Leishmania Viannia braziliensis
por: dos Santos, Rosiane Freire, et al.
Publicado: (2023)

Non-Leishmania Parasite in Fatal Visceral Leishmaniasis–like Disease, Brazil
por: Domagalska, Malgorzata Anna, et al.
Publicado: (2020)

Outbreak of Leishmania braziliensis Cutaneous Leishmaniasis, Saül, French Guiana
por: Martin-Blondel, Guillaume, et al.
Publicado: (2015)

Disseminated cutaneous leishmaniasis caused by Leishmania braziliensis in Southern Brazil
por: Membrive, Norberto Assis, et al.
Publicado: (2017)

Tracking of quiescence in Leishmania by quantifying the expression of GFP in the ribosomal DNA locus
por: Jara, Marlene, et al.
Publicado: (2019)

A New Target Organ of Leishmania (Viannia) braziliensis Chronic Infection: The Intestine
por: dos Santos, Amanda Gubert Alves, et al.
Publicado: (2021)

Targeted Deletion of Centrin in Leishmania braziliensis Using CRISPR-Cas9-Based Editing
por: Sharma, Rohit, et al.
Publicado: (2022)

Characterization of Neutrophil Function in Human Cutaneous Leishmaniasis Caused by Leishmania braziliensis
por: Conceição, Jacilara, et al.
Publicado: (2016)

The Paradoxical Leishmanicidal Effects of Superoxide Dismutase (SOD)-Mimetic Tempol in Leishmania braziliensis Infection in vitro
por: Oliveira, Laíse B., et al.
Publicado: (2019)

Generation and Characterization of a Dual-Reporter Transgenic Leishmania braziliensis Line Expressing eGFP and Luciferase
por: Sharma, Rohit, et al.
Publicado: (2020)

Effective Genome Editing in Leishmania (Viannia) braziliensis Stably Expressing Cas9 and T7 RNA Polymerase
por: Espada, Caroline R., et al.
Publicado: (2021)

Low doses of 3-phenyl-lawsone or meglumine antimoniate delivery by tattooing route are successful in reducing parasite load in cutaneous lesions of Leishmania (Viannia) braziliensis-infected hamsters
por: Meira, Rafaella de Miranda Villarim, et al.
Publicado: (2023)

Characterization of Differentially Abundant Proteins Among Leishmania (Viannia) braziliensis Strains Isolated From Atypical or Typical Lesions
por: Esteves, Bárbara B., et al.
Publicado: (2022)

miR-548d-3p Alters Parasite Growth and Inflammation in Leishmania (Viannia) braziliensis Infection
por: Souza, Marina de Assis, et al.
Publicado: (2021)

Meglumine antimoniate was associated with a higher cure rate than liposomal amphotericin B in the treatment of American tegumentary leishmaniasis: A retrospective cohort study from a Leishmania braziliensis-endemic area
por: Barroso, Daniel Holanda, et al.
Publicado: (2022)

Leishmania Exosomes/Extracellular Vesicles Containing GP63 Are Essential for Enhance Cutaneous Leishmaniasis Development Upon Co-Inoculation of Leishmania amazonensis and Its Exosomes
por: da Silva Lira Filho, Alonso, et al.
Publicado: (2022)

Comparative Gene Expression Analysis throughout the Life Cycle of Leishmania braziliensis: Diversity of Expression Profiles among Clinical Isolates
por: Adaui, Vanessa, et al.
Publicado: (2011)

Biomarkers of Cutaneous Leishmaniasis
por: Bahrami, Fariborz, et al.
Publicado: (2018)

Leptomonas seymouri Co-infection in Cutaneous Leishmaniasis Cases Caused by Leishmania donovani From Himachal Pradesh, India
por: Thakur, Lovlesh, et al.
Publicado: (2020)

Replacement of Leishmania (Leishmania) infantum Populations in an Endemic Focus of Visceral Leishmaniasis in Brazil
por: Valdivia, Hugo O., et al.
Publicado: (2022)

Novel Insights Into Leishmania (Viannia) braziliensis In Vitro Fitness Guided by Temperature Changes Along With Its Subtilisins and Oligopeptidase B
por: Zabala-Peñafiel, Anabel, et al.
Publicado: (2022)

Chemotherapeutic Potential of 17-AAG against Cutaneous Leishmaniasis Caused by Leishmania (Viannia) braziliensis
por: Santos, Diego M., et al.
Publicado: (2014)

Therapeutic Efficacy of Arnica in Hamsters with Cutaneous Leishmaniasis Caused by Leishmania braziliensis and L. tropica
por: Robledo, Sara M., et al.
Publicado: (2022)

Macromolecular biosynthetic parameters and metabolic profile in different life stages of Leishmania braziliensis: Amastigotes as a functionally less active stage
por: Jara, Marlene, et al.
Publicado: (2017)

A dysflagellar mutant of Leishmania (Viannia) braziliensis isolated from a cutaneous leishmaniasis patient
por: Zauli, Rogéria C, et al.
Publicado: (2012)

Miltefosine in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis in Brazil: A Randomized and Controlled Trial
por: Machado, Paulo R., et al.
Publicado: (2010)

Canine Cutaneous Leishmaniasis: Dissemination and Tissue Tropism of Genetically Distinct Leishmania (Viannia) braziliensis Populations
por: de Oliveira, Guilherme Marx, et al.
Publicado: (2013)

Failure of Liposomal-amphotericin B Treatment for New World Cutaneous Leishmaniasis due to Leishmania braziliensis
por: Kosaka, Atsushi, et al.
Publicado: (2020)

Prediction Score for Antimony Treatment Failure in Patients with Ulcerative Leishmaniasis Lesions
por: Valencia, Cristian, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_4khdor1v1ef954v1jnjnkdn8ra